Cross-talk between xenobiotic detoxication and other signalling pathways: clinical and toxicological consequences

Reference

• ABDEL-RAZZAK, Z., LOYER, P., FAUTREL, A., GAUTIER, J. C., CORCOS, L., TURLIN, B., BEAUNE, P. and Gun,',ouzo, A., 1993, Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Molecular Pharmacology, 44,707–715.
   Google Scholar
• ACHATZ, G., HOLZL, B., SPECKMAYER, R., HAUSER, C., SANDHOFER, F. and PAULWEBER, B., 1997, Functional domains of the human orphan receptor ARP-1/COUP-TFII involved in active repression and transrepression. Molecular Cell Biology, 17, 4914–4932.
   PubMed Web of Science ®Google Scholar
• ApcocK, I. M. and CARAMORI, G., 2001, Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunology and Cell Biology, 79, 376–384.
   PubMed Web of Science ®Google Scholar
• AKIYAMA, T. E. and GONZALEZ, F. J., 2003, Regulation of P450 genes by liver-enriched transcription factors and nuclear receptors. Biochimica et Biophysica Acta, 1619, 223–234.
   PubMed Web of Science ®Google Scholar
• AKNER, G., WIKSTROM, A. C. and GUSTAFSSON, J. A., 1995, Subcellular distribution of the glucocorticoid receptor and evidence for its association with microtubules. Journal of Steroid Biochemistry and Molecular Biology, 52, 1–16.
   PubMed Web of Science ®Google Scholar
• Aso, T., CONAWAY, J. W. and CONAWAY, R. C., 1995, The RNA polymerase II elongation complex. FASEB Journal, 9, 1419–1428.
   PubMed Web of Science ®Google Scholar
• ASSENAT, E., GERBAL-CHALOIN, S., LARREY, D., SARIC, J., FABRE, J. M., MAUREL, P., VILAREM, M. J. and PASCUSSI, J. M., 2004, Interleukin-113 suppresses CAR-induced expression of hepatic genes involved in drug and bilirubin clearance: role of NFkB in CAR gene repression. Hepatology (in press).
   Google Scholar
• AUERBACH, S. S., RAMSDEN, R., STONER, M. A., VERLINDE, C., HASSETT, C. and OMIECINSKI, C. J., 2003, Alternatively spliced isoforms of the human constitutive androstane receptor. Nucleic Acids Research, 31, 3194–3207.
   PubMed Web of Science ®Google Scholar
• AUMAIS, J. P., LEE, H. S., DEGANNES, C., HORSFORD, J. and WHITE, J. H., 1996, Function of directly repeated half-sites as response elements for steroid hormone receptors. Journal of Biological Chemistry, 271, 12568–12577.
   PubMed Web of Science ®Google Scholar
• BABA, T., MIMURA, J., GRADIN, K., KUROIWA, A., WATANABE, T., MATSUDA, Y INAZAWA, J., SOGAWA, K. and FUJII-KURIYAMA, Y., 2001, Structure and expression of the Ah receptor repressor gene. Journal of Biological Chemistry, 276, 33101–33110.
   Google Scholar
• BAES, M., GULICK, T., CHOI, H. S., MARTINOLI, M. G., SIMHA, D. and MOORE, D. D., 1994, A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Molecular Cell Biology, 14, 1544–1551.
   PubMed Web of Science ®Google Scholar
• BARKER, C. W., FAGAN, J. B. and PASCO, D. S., 1992, Interleukin-1 beta suppresses the induction of P4501A1 and P4501A2 mRNAs in isolated hepatocytes. Journal of Biological Chemistry, 267, 8050–8055.
   PubMed Web of Science ®Google Scholar
• BEELMAN, C. A. and PARKE R., 1995, Degradation of mRNA in eukaryotes. Cell, 81, 179–183.
   PubMed Web of Science ®Google Scholar
• BEIGNEUX, A. P., MOSER, A. H., SHIGENAGA, J. K., GRUNFELD, C. and FEINGOLD, K. R., 2002, Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response. Biochemical and Biophysical Research Communications, 293, 145–149.
   PubMed Web of Science ®Google Scholar
• BEISCHLAG, T. V., WANG, S., ROSE, D. W., TORCHIA, J., REISZ-PORSZASZ, S., MUHAMMAD, K., NELSON, W. E., PROBST, M. R., ROSENFELD, M. G. and HANKINSON, 0., 2002, Recruitment of the NCoA/ SRC-1/p160 family of transcriptional coactivators by the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator complex. Molecular Cell Biology, 22, 4319–4333.
   Google Scholar
• BELANDIA, B. and PARKER, M. G., 2003, Nuclear receptors: a rendezvous for chromatin remodeling factors. Cell, 114, 277–280.
   PubMed Web of Science ®Google Scholar
• BEN-CHETRIT, E. and LEVY, M., 1998, Colchicine: 1998 update. Seminars in Arthritis and Rheumatism, 28, 48–59.
   PubMed Web of Science ®Google Scholar
• BERTILSSON, G., HEIDRICH, J., SVENSSON, K., ASMAN, M., JENDEBERG, L., SYDOW-BACKMAN, M., OHLSSON, R., POSTLIND, H., BLOMQUIST, P. and BERKENSTAM, A., 1998, Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proceedings of the National Academy of Sciences, USA, 95, 12208–12213.
   Google Scholar
• BLACKWOOD, E. M. and KADONAGA, J. T., 1998, Going the distance: a current view of enhancer action. Science, 281, 61–63.
   Web of Science ®Google Scholar
• BLUMBERG, B., KANG, H., BOLADO, J., JR, CHEN, H., CRAIG, A. G., MORENO, T. A., UMESONO, K., PERLMANN, T., DEROBERTIS, E. M. and EVANS, R. M., 1998a, BXR, an embryonic orphan nuclear receptor activated by a novel class of endogenous benzoate metabolites. Genes and Development, 12, 1269–1277.
   Google Scholar
• BLUMBERG, B., SABBAGH, W., JR, JUGUILON, H., BOLADO, J., JR, VAN METER, C. M., ONG, E. S. and EVANS, R. M., 1998b, SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes and Development, 12, 3195–3205.
   Google Scholar
• BOCK, K. W., 1994, Aryl hydrocarbon or dioxin receptor: biologic and toxic responses. Reviews in Physiology, Biochemistry and Pharmacology, 125, 1–42.
   PubMedGoogle Scholar
• BOURGUET, W., GERMAIN, P. and GRONEMEYER, H., 2000, Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. Trends in Pharmacology Science, 21, 381–388.
   PubMed Web of Science ®Google Scholar
• BRIVANLOU, A. H. and DARNELL, J. E., JR, 2002, Signal transduction and the control of gene expression. Science, 295, 813–818.
   PubMed Web of Science ®Google Scholar
• BRODIE, M. J., BOOBIS, A. R., HILLYARD, C. J., ABEYASEKERA, G., STEVENSON, J. C., MACINTYRE, I. and PARK, B. K., 1982, Effect of rifampicin and isoniazid on vitamin D metabolism. Clinical Pharmacology and Therapy, 32, 525–530.
   PubMed Web of Science ®Google Scholar
• BRZOZOWSKI, A. M., PIKE, A. C., DAUTER, Z., HUBBARD, R. E., BONN, T., ENGSTROM, 0., OHMAN, L., GREENE, G. L., GUSTAFSSON, J. A. and CARLQUIST, M., 1997, Molecular basis of agonism and antagonism in the oestrogen receptor. Nature, 389, 753–758.
   Google Scholar
• BURBACH, K. M., POLAND, A. and BRADFIELD, C. A., 1992, Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proceedings of the National Academy of Sciences, USA, 89, 8185–8189.
   PubMed Web of Science ®Google Scholar
• CHAN, T. Y., 1996, Osteomalacia during rifampicin and isoniazid therapy is rare in Hong Kong. International Journal of Clinical Pharmacology and Therapy, 34, 533–534.
   PubMed Web of Science ®Google Scholar
• CHAN, W. K., YAO, G., Gu, Y. Z. and BRADFIELD, C. A., 1999, Cross-talk between the aryl hydrocarbon receptor and hypoxia inducible factor signaling pathways. Demonstration of competition and compensation. Journal of Biological Chemistry, 274, 12115–12123.
   PubMed Web of Science ®Google Scholar
• CHEN, Y., FERGUSON, S. S., NEGISHI, M. and GOLDSTEIN, J. A., 2003, Identification of constitutive androstane receptor and glucocorticoid receptor binding sites in the CYP2C19 promoter. Molecular Pharmacology, 64, 316–324.
   PubMed Web of Science ®Google Scholar
• COMMITTEE, N. R. N., 1999, A unified nomenclature system for the nuclear receptor superfamily. Cell, 97, 161–163.
   PubMed Web of Science ®Google Scholar
• COONEY, A. J., LENG, X., TSAI, S. Y., O'MALLEY, B. W. and TSAI, M. J., 1993, Multiple mechanisms of chicken ovalbumin upstream promoter transcription factor-dependent repression of transactivation by the vitamin D, thyroid hormone, and retinoic acid receptors. Journal of Biological Chemistry, 268, 4152–4160.
   Google Scholar
• CRAMER, P., BUSHNELL, D. A. and KORNBERG, R. D., 2001, Structural basis of transcription: RNA polymerase II at 2. 8 angstrom resolution. Science, 292, 1863–1876.
   PubMed Web of Science ®Google Scholar
• CURTIS, D., LEHMANN, R. and ZAMORE, P. D., 1995, Translational regulation in development. Cell, 81, 171–178.
   PubMed Web of Science ®Google Scholar
• DANIELSSON, C., MATHIASEN, I. S., JAMES, S. Y., NAYERI, S., BRETTING, C., HANSEN, C. M., COLSTON, K. W. and CARLBERG, C., 1997, Sensitive induction of apoptosis in breast cancer cells by a novel 1,25-dihydroxyvitamin D3 analogue shows relation to promoter selectivity. Journal of Cell Biochemistry, 66, 552–562.
   PubMed Web of Science ®Google Scholar
• DAUJAT, M., CHARRASSE, S., FABRE, I., LESCA, P., JOUNAIDI, Y., LARROQUE, C., POELLINGER, L. and MAUREL, P., 1996, Induction of CYP1A1 gene by benzimidazole derivatives during Caco-2 cell differentiation. Evidence for an aryl-hydrocarbon receptor-mediated mechanism. European Journal of Biochemistry, 237, 642–652.
   PubMedGoogle Scholar
• DEVIrro, M. J., THOMAS, T., MARTIN, E., UMBREIT, T. H. and GALLO, M. A., 1992, Antiestrogenic action of 2,3,7,8-tetrachlorodibenzo-p-dioxin: tissue-specific regulation of estrogen receptor in CD1 mice. Toxicology and Applied Pharmacology, 113, 284–292.
   PubMed Web of Science ®Google Scholar
• DIAZ, D., FABRE, I., DAUJAT, M., Saint AUBERT, B., BORIES, P., MICHEL, H. and MAUREL, P., 1990, Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. Gastroenterology, 99, 737–747.
   PubMed Web of Science ®Google Scholar
• DOTZLAW, H., LEYGUE, E., WATSON, P. and MURPHY, L. C., 1999, The human orphan receptor PXR messenger RNA is expressed in both normal and neoplastic breast tissue. Clinical Cancer Research, 5, 2103–2107.
   PubMed Web of Science ®Google Scholar
• DROCOURT, L., OURLIN, J. C., PASCUSSI, J. M., MAUREL, P. and VILAREM, M. J., 2002, Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes. Journal of Biological Chemistry, 277, 25125–25132.
   PubMed Web of Science ®Google Scholar
• DUAN, R., PORTER, W., SAMUDIO, I., VYHLIDAL, C., KLADDE, M. and SAFE, S., 1999, Transcriptional activation of c-fos protooncogene by 17beta-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition. Molecular Endocrinology, 13, 1511–1521.
   PubMed Web of Science ®Google Scholar
• DUSSAULT, I., Yoo, H. D., LIN, M., WANG, E., FAN, M., BATTA, A. K., SALEN, G., ERICKSON, S. K. and FORMAN, B. M., 2003, Identification of an endogenous ligand that activates pregnane X receptor-mediated sterol clearance. Proceedings of the National Academy of Sciences, USA, 100, 833–838.
   PubMed Web of Science ®Google Scholar
• DVORAK, Z., MODRIANSKY, M., PICHARD-GARCIA, L., BALAGUER, P., VILAREM, M. J., ULRICHOVA, J., MAUREL, P. and PASCUSSI, J. M., 2003, Colchicine down-regulates cytochrome P450 2B6, 2C8, 2C9, and 3A4 in human hepatocytes by affecting their glucocorticoid receptor-mediated regulation. Molecular Pharmacology, 64, 160–169.
   Google Scholar
• DZELETOVIC, N., McGuIEE, J., DAUJAT, M., THOLANDER, J., EMA, M., FUJII-KURIYAMA, Y., BERGMAN, J., MAUREL, P. and POELLINGER, L., 1997, Regulation of dioxin receptor function by omeprazole. Journal of Biological Chemistry, 272, 12705–12713.
   Google Scholar
• EDWARDS, D. P., 1999, Coregulatory proteins in nuclear hormone receptor action. Vitamins and Hormones, 55, 165–218.
   PubMed Web of Science ®Google Scholar
• EcucHI, H., IEuTA, T., TACHIBANA, T., YONEDA, Y. and KAwAimi, K., 1997, A nuclear localization signal of human aryl hydrocarbon receptor nuclear translocator/hypoxia-inducible factor lbeta is a novel bipartite type recognized by the two components of nuclear pore-targeting complex. Journal of Biological Chemistry, 272, 17640–17647.
   PubMed Web of Science ®Google Scholar
• EKINS, S., MIRNY, L. and SCHUETZ, E. G., 2002, A ligand-based approach to understanding selectivity of nuclear hormone receptors PXR, CAR, FXR, LXRalpha, and LXRbeta. Pharmacology Research, 19, 1788–1800.
   Web of Science ®Google Scholar
• EMA, M., HIROTA, K., MIMURA, J., ABE, H., YODOI, J., SOGAWA, K., POELLINGER, L. and FUJII-KURIYAMA, Y., 1999, Molecular mechanisms of transcription activation by HLF and HIF1 alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. EMBO Journal, 18, 1905–1914.
   Google Scholar
• FABER, K. N., MULLER, M. and JANSEN, P. L., 2003, Drug transport proteins in the liver. Advances in Drug Delivery Reviews, 55, 107–124.
   PubMed Web of Science ®Google Scholar
• FERNANDEZ-SALGUERO, P. M., WARD, J. M., SUNDBERG, J. P. and GONZALEZ, F. J., 1997, Lesions of aryl-hydrocarbon receptor-deficient mice. Veterinary Pathology, 34, 605–614.
   Google Scholar
• FORMAN, B. M., TZAMELI, I., CHOI, H. S., CHEN, J., SIMHA, D., SEOL, W., EVANS, R. M. and MOORE, D. D., 1998, Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta. Nature, 395, 612–615.
   PubMed Web of Science ®Google Scholar
• FRANCIS, G. A., FAYARD, E., PICARD, F. and AUWERX, J., 2003, Nuclear receptors and the control of metabolism. Annual Reviews in Physiology, 65, 261–311.
   PubMed Web of Science ®Google Scholar
• FRANK, C., GONZALEZ, M. M., OINONEN, C., DUNLOP, T. W. and CARLBERG, C., 2003, Characterization of DNA complexes formed by the nuclear receptor constitutive androstane receptor. Journal of Biological Chemistry, 278, 43299–43310.
   PubMed Web of Science ®Google Scholar
• FRASER, D. J., ZUMSTEG, A. and MEYER, U. A., 2003, Nuclear receptors constitutive androstane receptor and pregnane X receptor activate a drug-responsive enhancer of the murine 5-aminolevulinic acid synthase gene. Journal of Biological Chemistry, 278, 39392–39401.
   PubMed Web of Science ®Google Scholar
• GALIGNIANA, M. D., HOUSLEY, P. R., DEFRANCO, D. B. and PRATT, W. B., 1999, Inhibition of glucocorticoid receptor nucleocytoplasmic shuttling by okadaic acid requires intact cytoskeleton. Journal of Biological Chemistry, 274, 16222–16227.
   PubMed Web of Science ®Google Scholar
• GALIGNIANA, M. D., SCRUGGS, J. L., HERRINGTON, J., WELSH, M. J., CARTER-SU, C., HOUSLEY, P. R. and PRATT, W. B., 1998, Heat shock protein 90-dependent (geldanamycin-inhibited) movement of the glucocorticoid receptor through the cytoplasm to the nucleus requires intact cytoskeleton. Molecular Endocrinology, 12, 1903–1913.
   Google Scholar
• GALVA N., JASKULA-SZTUL, R., MACWILLIAMS, P. S., CZUPRYNSKI, C. J. and JEFCOATE, C. R., 2003, Bone marrow cytotoxicity of benzo[a]pyrene is dependent on CYP1B1 but is diminished by Ah receptor-mediated induction of CYP1A1 in liver. Toxicology and Applied Pharmacology, 193, 84–96.
   Google Scholar
• GARDNER-STEPHEN, D., HEYDEL, J. M., GOYAL, A., Lu, Y., XIE, W., LINDBLOM, T., MACKENZIE, P. and RADOMINSKA-PANDYA, A., 2004, Human PXR variants and their differential effects on the regulation of human UDP-glucuronosyltransferase gene expression. Drug Metabolism and Disposition, 32, 340–347.
   Google Scholar
• GEICK, A., EICHELBAU M. and BURR, 0., 2001, Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. Journal of Biological Chemistry, 276, 14581–14587.
   Google Scholar
• GERBAL-CHALOIN, S., DAUJAT, M., PASCUSSI, J. M., PICHARD-GARCIA, L., VILAREM, M. J. and MAUREL, P., 2002, Transcriptional regulation of CYP2C9 gene. Role of glucocorticoid receptor and constitutive androstane receptor. Journal of Biological Chemistry, 277, 209–217.
   Google Scholar
• GHOSH, S., 1999, Regulation of inducible gene expression by the transcription factor NF-kappaB. Immunology Research, 19, 183–189.
   PubMed Web of Science ®Google Scholar
• GIGUERE, V., 1999, Orphan nuclear receptors: from gene to function. Endocrine Reviews, 20, 689–725. GILLESBY, B. E., STANOSTEFANO, M., PORTER, W., SAFE, S., Wu, Z. F. and ZACHAREWSKI, T. R., 1997, Identification of a motif within the 5' regulatory region of p52 which is responsible for AP–1 binding and TCDD-mediated suppression. Biochemistry, 36, 6080-6089.
   Google Scholar
• GLASS, C. K. and ROSENFELD, M. G., 2000, The coregulator exchange in transcriptional functions of nuclear receptors. Genes and Development, 14, 121–141.
   PubMed Web of Science ®Google Scholar
• GNATT, A. L., CRAMER, P., Fu, J., BUSHNELL, D. A. and KORNBERG, R. D., 2001, Structural basis of transcription: an RNA polymerase II elongation complex at 3.3 A resolution. Science, 292, 1876–1882.
   PubMed Web of Science ®Google Scholar
• GONZALEZ, F. J., 1992, Human cytochromes P450: problems and prospects. Trends in Pharmacology Science, 13, 346–352.
   PubMed Web of Science ®Google Scholar
• GONZALEZ, F. J. and Fernandez-SALoumo, P., 1998, The aryl hydrocarbon receptor: studies using the AHR-null mice. Drug Metabolism and Disposition, 26, 1194–1198.
   Google Scholar
• GOODBOURN, 1996, Eukaryotic Gene Transcription (Oxford: IRL Press).
   Google Scholar
• GOODWIN, B., GAUTHIER, K. C., UMETANI, M., WATSON, M. A., LOCHANSKY, M. I., COLLINS, J. L., LEITERSDORF, E., MANGELSDORF, D. J., KLIEWER, S. A. and REPA, J. J., 2003, Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor. Proceedings of the National Academy of Sciences, USA, 100, 223–228.
   PubMed Web of Science ®Google Scholar
• GOODWIN, B., HODGSON, E. and LIDDLE, C., 1999, The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Molecular Pharmacology, 56, 1329–1339.
   PubMed Web of Science ®Google Scholar
• GOODWIN, B., HODGSON, E., D'CosTA, D. J., ROBERTSON, G. R. and LIDDLE, C., 2002, Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor. Molecular Pharmacology, 62, 359–365.
   Google Scholar
• GOODWIN, B., JONES, S. A., PRICE, R. R., WATSON, M. A., McKEE, D. D., MOORE, L. B., GALARDI, C., WILSON, J. G., LEWIS, M. C., ROTH, M. E., MALONEY, P. R., WILLSON, T. M. and KLIEWER, S. A., 2000, A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Molecular Cell, 6, 517–526.
   PubMed Web of Science ®Google Scholar
• GOODWIN, B., MOORE, L. B., STOLTZ, C. M., MCKEE, D. D. and KLIEWER, S. A., 2001, Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor. Molecular Pharmacology, 60, 427–431.
   PubMed Web of Science ®Google Scholar
• GRADIN, K., McGuirtE, J., WENGER, R. H., KVIETIKOVA, I., FHITELAW, M. L., TOFTGARD, R., TORA, L., GASSMANN, M. and POELLINGER, L., 1996, Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor. Molecular Cell Biology, 16, 5221–5231.
   PubMed Web of Science ®Google Scholar
• GROZINGER, C. M. and SCHREIBER, S. L., 2002, Deacetylase enzymes: biological functions and the use of small-molecule inhibitors. Chemistry and Biology, 9, 3–16.
   PubMed Web of Science ®Google Scholar
• GUSTAFSSON, J. A., 2003, What pharmacologists can learn from recent advances in estrogen signalling. Trends in Pharmacology Science, 24, 479–485.
   PubMed Web of Science ®Google Scholar
• HAHN, M. E., 1998, The aryl hydrocarbon receptor: a comparative perspective. Comp in Biochemistry and Physiology C: Pharmacology, Toxicology and Endocrinology, 121, 23–53.
   Google Scholar
• HANDSCHIN, C., PODVINEC, M., AMHERD, R., LOOSER, R., OURLIN, J. C. and MEYER, U. A., 2002, Cholesterol and bile acids regulate xenosensor signaling in drug-mediated induction of cytochromes P450. Journal of Biological Chemistry, 277, 29561–29567.
   PubMed Web of Science ®Google Scholar
• HANDSCHIN, C., PODVINEC, M., STOCKLI, J., HOFFMANN, K. and MEYER, U. A., 2001, Conservation of signaling pathways of xenobiotic-sensing orphan nuclear receptors, chicken xenobiotic receptor, constitutive androstane receptor, and pregnane X receptor, from birds to humans. Molecular Endocrinology, 15, 1571–1585.
   PubMed Web of Science ®Google Scholar
• HANKINSON, 0., 1995, The aryl hydrocarbon receptor complex. Annual Reviews in Pharmacology and Toxicology, 35, 307–340.
   Google Scholar
• HANNA-ROSE, W. and HANSEN, U., 1996, Active repression mechanisms of eukaryotic transcription repressors. Trends in Genetics, 12, 229–234.
   PubMed Web of Science ®Google Scholar
• HERTZ, R., MAGENHEIM, J., BERMAN, I. and BAR-TANA, J., 1998, Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4alpha. Nature, 392, 512–516.
   Google Scholar
• HILL, D., SHEDLOFSKY, S., MCCLAIN, C., DIEHL, A. M. and TSUKAMOTO, H., 1997, Cytokines in Health and Disease (New York), pp. 401–425.
   Google Scholar
• HONKAKOSKI, P., ZELKO, I., SUEYOSHI, T. and NEGISHI, M., 1998, The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Molecular Cell Biology, 18, 5652–5658.
   PubMed Web of Science ®Google Scholar
• HUANG, W., ZHANG, J. and MOORE, D. D., 2004, A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR. Journal in Clinical Investigation, 113, 137–143.
   PubMed Web of Science ®Google Scholar
• HUANG, W., ZHANG, J., CHUA, S. S., QATANANI, M., HAN, Y., GRANATA, R. and MOORE, D. D., 2003, Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proceedings of the National Academy of Sciences, USA, 100, 4156–4161.
   PubMed Web of Science ®Google Scholar
• Huss, J. M. and KASPER, C. B., 1998, Nuclear receptor involvement in the regulation of rat cytochrome P450 3A23 expression. Journal of Biological Chemistry, 273, 16155–16162.
   PubMed Web of Science ®Google Scholar
• HUSTERT, E., ZIBAT, A., PRESECAN-SIEDEL, E., EISELT, R., MUELLER, R., Fuss, C., BREHM, I., BRINKMANN, U., EICHELBAUM, M., WOJNOWSKI, L. and BURR, 0., 2001, Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4. Drug Metabolism and Disposition, 29, 1454–1459.
   Google Scholar
• IKUTA, T., EGUCHI, H., TACHIBANA, T., YONEDA, Y. and KAWAJIRI, K., 1998, Nuclear localization and export signals of the human aryl hydrocarbon receptor. Journal of Biological Chemistry, 273, 2895–2904.
   PubMed Web of Science ®Google Scholar
• ISRAEL, D. I., ESTOLANO, M. G., GALEAZZI, D. R. and WHITLOCK, J. P., JR, 1985, Superinduction of cytochrome P1-450 gene transcription by inhibition of protein synthesis in wild type and variant mouse hepatoma cells. Journal of Biological Chemistry, 260, 5648–5653.
   PubMed Web of Science ®Google Scholar
• JANA, N. R., SARKAR, S., ISHIZUKA, M., YONEMOTO, J., TOHYAMA, C. and SONE, H., 1999, Role of estradiol receptor-alpha in differential expression of 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible genes in the RL95-2 and KLE human endometrial cancer cell lines. Archives in Biochemistry and Biophysics, 368, 31–39.
   PubMed Web of Science ®Google Scholar
• JENUWEIN, T. and Aws, C. D., 2001, Translating the histone code. Science, 293, 1074–1080.
   PubMed Web of Science ®Google Scholar
• JOHANSSON, L., THOMSEN, J. S., DAMDIMOPOULOS, A. E., SPYROU, G., GUSTAFSSON, J. A. and TREUTER, E., 1999, The orphan nuclear receptor SHP inhibits agonist-dependent transcriptional activity of estrogen receptors ERalpha and ERbeta. Journal of Biological Chemistry, 274, 345–353.
   PubMed Web of Science ®Google Scholar
• JovER, R., BORT, R., GOMEZ-LECHON, M. J. and CASTELL, J. V., 2001, Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: a study using adenovirus-mediated antisense targeting. Hepatology, 33, 668–675.
   Google Scholar
• KAMIYA, A., INouE, Y. and GONZALEZ, F. J., 2003, Role of the hepatocyte nuclear factor 4alpha in control of the pregnane X receptor during fetal liver development. Hepatology, 37, 1375-1384. KARIN, M., 1999, How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene, 18, 6867–6874.
   Google Scholar
• KAST, H. R., GOODWIN, B., TARR, P. T., JONES, S. A., ANISFELD, A. M., STOLTZ, C. M., TONTONOZ, P., KLIEWER, S., WILLSON, T. M. and EDWARDS, P. A., 2002, Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. Journal of Biological Chemistry, 277, 2908–2915.
   PubMed Web of Science ®Google Scholar
• KATO, S., 2000, The function of vitamin D receptor in vitamin D action. Journal of Biochemistry (Tokyo), 127, 717–722.
   PubMed Web of Science ®Google Scholar
• KAWAMOTO, T., SUEYOSHI, T., ZELKO, I., MOORE, R., WASHBURN, K. and NEGISHI, M., 1999, Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Molecular Cell Biology, 19, 6318–6322.
   PubMed Web of Science ®Google Scholar
• KAWANA, K., IKUTA, T., KOBAYASHI, Y., GOTOH, 0., TAKEDA, K. and KAWAJIRI, K., 2003, Molecular mechanism of nuclear translocation of an orphan nuclear receptor, SXR. Molecular Pharmacology, 63, 524–531.
   Google Scholar
• KAZLAUSKAS, A., SUNDSTROM, S., POELLINGER, L. and PONGRATZ, I., 2001, The hsp90 chaperone complex regulates intracellular localization of the dioxin receptor. Molecular Cell Biology, 21, 2594–2607.
   PubMed Web of Science ®Google Scholar
• KE, S., RABSON, A. B., GERMINO, J. F., GALLO, M. A. and TIAN, Y., 2001, Mechanism of suppression of cytochrome P-450 1A1 expression by tumor necrosis factor-alpha and lipopolysaccharide. Journal of Biological Chemistry, 276, 39638–39644.
   PubMed Web of Science ®Google Scholar
• KHATSENKO, 0. G., BOOBIS, A. R. and GROSS, S. S., 1997, Evidence for nitric oxide participation in down-regulation of CYP2B1/2 gene expression at the pretranslational level. Toxicology Letters, 90, 207–216.
   Google Scholar
• KLIEWER, S. A., LEHMANN, J. M. and WILLSON, T. M., 1999, Orphan nuclear receptors: shifting endocrinology into reverse. Science, 284, 757–760.
   PubMed Web of Science ®Google Scholar
• KLIEWER, S. A., MOORE, J. T., WADE, L., STAUDINGER, J. L., WATSON, M. A., JoNEs, S. A., McKEE, D. D., OLIVER, B. B., WILLSON, T. M., ZETTERSTROM, R. H., PERLMANN, T. and LEHMANN, J. M., 1998, An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell, 92, 73–82.
   PubMed Web of Science ®Google Scholar
• KOBAYASHI, A., NUMAYAMA-TSURUTA, K., SOGAWA, K. and FUJII-KURIYAMA, Y., 1997, CBP/p300 functions as a possible transcriptional coactivator of Ah receptor nuclear translocator (Arnt). Journal of Biochemistry (Tokyo), 122, 703–710.
   Google Scholar
• KOBAYASHI, K., SUEYOSHI, T., INouE, K., MOORE, R. and NEGISHI, M., 2003, Cytoplasmic accumulation of the nuclear receptor CAR by a tetratricopeptide repeat protein in HepG2 cells. Molecular Pharmacology, 64, 1069–1075.
   PubMed Web of Science ®Google Scholar
• KOYANO, S., KUROSE, K., SAITO, Y., OZAWA, S., HASEGAWA, R., KOMAMURA, K., UENO, K., KAMAKURA, S., KITAKAZE, M., NAKAJIMA, T., MATSUMOTO, K., AKASAWA, A., SAITO, H. and SAWADA, J., 2004, Functional characterization of four naturally occurring variants of human pregnane X receptor (PXR): one variant causes dramatic loss of both DNA binding activity and the transactivation of the CYP3A4 promoter/enhancer region. Drug Metabolism and Disposition, 32, 149–154.
   PubMed Web of Science ®Google Scholar
• KRISHNAN, V., PORTER, W., SANTOSTEFANO, M., WANG, X. and SAFE, S., 1995, Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells. Molecular Cell Biology, 15, 6710–6719.
   PubMed Web of Science ®Google Scholar
• KTISTAKI, E. and TALIANIDIS, I., 1997, Chicken ovalbumin upstream promoter transcription factors act as auxiliary cofactors for hepatocyte nuclear factor 4 and enhance hepatic gene expression. Molecular Cell Biology, 17, 2790–2797.
   PubMed Web of Science ®Google Scholar
• KUMAR, M. B., TARPEY, R. W. and PERDEW, G. H., 1999, Differential recruitment of coactivator RIP140 by Ah and estrogen receptors. Absence of a role for LXXLL motifs. Journal of Biological Chemistry, 274, 22155–22164.
   PubMed Web of Science ®Google Scholar
• Kuo, C. J., CONLEY, P. B., CHEN, L., SLADEK, F. M., DARNELL, J. E., JR and CRABTREE, G. R., 1992, A transcriptional hierarchy involved in mammalian cell-type specification. Nature, 355, 457–461.
   PubMed Web of Science ®Google Scholar
• LECLUYSE, E. L., 2001, Pregnane X receptor: molecular basis for species differences in CYP3A induction by xenobiotics. Chemistry and Biology Interactions, 134, 283–289.
   PubMed Web of Science ®Google Scholar
• LEE, J., OBACH, R. and FISHER, M., 2003, Drug Metabolizing Enzymes. Cytochrome P450 and Other Enzymes in Drug Discovery and Development (Lausanne: FontisMedia SA and New York: Marcel Dekker).
   Google Scholar
• LEE, T. I. and YOUNG, R. A., 2000, Transcription of eukaryotic protein-coding genes. Annual Reviews in Genetics, 34, 77–137.
   PubMed Web of Science ®Google Scholar
• LEHMANN, J. M., MCKEE, D. D., WATSON, M. A., WILLSON, T. M., MOORE, J. T. and KLIEWER, S. A., 1998, The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. Journal in Clinical Investigation, 102, 1016–1023.
   PubMed Web of Science ®Google Scholar
• LI, J., NING, G. and DUNCAN, S. A., 2000, Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha. Genes and Development, 14, 464–474.
   PubMed Web of Science ®Google Scholar
• LI-MASTERS, T. and MORGAN, E. T., 2001, Effects of bacterial lipopolysaccharide on phenobarbital-induced CYP2B expression in mice. Drug Metabolism and Disposition, 29, 252–257.
   PubMed Web of Science ®Google Scholar
• LI-MASTERS, T. and MORGAN, E. T., 2002, Down-regulation of phenobarbital-induced cytochrome P4502B mRNAs and proteins by endotoxin in mice: independence from nitric oxide production by inducible nitric oxide synthase. Biochemical Pharmacology, 64, 1703–1711.
   Web of Science ®Google Scholar
• LIN, J. H. and Lu, A. Y., 1998, Inhibition and induction of cytochrome P450 and the clinical implications. Clinical Pharmacokinetics, 35, 361–390.
   PubMed Web of Science ®Google Scholar
• LIN, T. M., Ko, K., MOORE, R. W., SIMANAINEN, U., OBERLEY, T. D. and PETERSON, R. E., 2002, Effects of aryl hydrocarbon receptor null mutation and in utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on prostate and seminal vesicle development in C57BL/6 mice. Toxicology Science, 68, 479–487.
   PubMed Web of Science ®Google Scholar
• MA, Q., 2001, Induction of CYP1A1. The AhR/DRE paradigm: transcription, receptor regulation, and expanding biological roles. Current Drug Metabolism, 2, 149–164.
   PubMed Web of Science ®Google Scholar
• MAGLICH, J. M., PARKS, D. J., MOORE, L. B., COLLINS, J. L., GOODWIN, B., BILLIN, A. N., STOLTZ, C.
   Google Scholar
• A., KLIEWER, S. A., LAMBERT, M. H., WILLSON, T. M. and MOORE, J. T., 2003, Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. Journal of Biological Chemistry, 278, 17277–17283.
   Google Scholar
• MAKINEN, J., REINISALO, M., NIEMI, K., VIITALA, P., JYRKKARINNE, J., CHUNG, H., PELKONEN, 0. and HONKAKOSKI, P., 2003, Dual action of oestrogens on the mouse constitutive androstane receptor. Biochemistry Journal, 376, 465–472.
   Google Scholar
• MAKISHIMA, M., Lu, T. T., XIE, W., WHITFIELD, G. K., DOMOTO, H., EVANS, R. M., HAUSSLER, M. R. and MANGELSDORF, D. J., 2002, Vitamin D receptor as an intestinal bile acid sensor. Science, 296, 1313–1316.
   PubMed Web of Science ®Google Scholar
• MANGELSDORF, D. J. and EVANS, R. M., 1995, The RXR heterodimers and orphan receptors. Cell, 83, 841–850.
   PubMed Web of Science ®Google Scholar
• MANGELSDORF, D. J., THUMMEL, C., BEATO, M., HERRLICH, P., SCHUTZ, G., UMESONO, K., BLUMBERG, B., KASTNER, P., MARK, M., CHAMBON, P. and EVANS, R. M., 1995, The nuclear receptor superfamily: the second decade. Cell, 83, 835–839.
   Google Scholar
• MAUREL, P., 1996, The CYP3 family. In Ioannides, C. (ed.), Cytochromes P450 Metabolic and Toxicological Aspects (Boca Raton: CRC Press), pp. 241–270.
   Google Scholar
• MCDONNELL, D. P. and NORRIS, J. D., 2002, Connections and regulation of the human estrogen receptor. Science, 296, 1642–1644.
   PubMed Web of Science ®Google Scholar
• MCINNES, G. T. and BRODIE, M. J., 1988, Drug interactions that matter. A critical reappraisal. Drugs, 36, 83–110.
   PubMed Web of Science ®Google Scholar
• McKAv, L. I. and CIDLowsKI, J. A., 1998, Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism. Molecular Endocrinology, 12, 45–56.
   PubMedGoogle Scholar
• MEYER, B. K., PRAY-GRANT, M. G., VANDEN HEUVEL, J. P. and PERDEW, G. H., 1998, Hepatitis B virus X-associated protein 2 is a subunit of the unliganded aryl hydrocarbon receptor core complex and exhibits transcriptional enhancer activity. Molecular Cell Biology, 18, 978–988.
   Google Scholar
• MIMURA, J., EMA, M., SOGAWA, K., FUJII-KURIYAMA, Y. and INAZAWA, J., 1999, Identification of a novel mechanism of regulation of Ah (dioxin) receptor function. Genes and Development, 13, 20–25.
   Google Scholar
• MIMURA, J. and FUJII-KURIYAMA, Y., 2003, Functional role of AhR in the expression of toxic effects by TCDD. Biochimica et Biophysica Acta, 1619, 263–268.
   Google Scholar
• MIMURA, J., YAMASHITA, K., NAKAMURA, K., MORITA, M., TAKAGI, T. N., NAKAO, K., EMA, M., SOGAWA, K., YASUDA, M., KATSUKI, M. and FUJII-KURIYAMA, Y., 1997, Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes and Cells, 2, 645–654.
   Google Scholar
• MOOCHHALA, S. M., 1991, Alteration of drug biotransformation by interferon and host defence mechanism. Annals of the Academy of Medicine of Singapore, 20, 13–18.
   PubMedGoogle Scholar
• MOORE, L. B., GOODWIN, B., JONES, S. A., WISELY, G. B., SERABJIT-SINGH, C. J., WILLSON, T. M., COLLINS, J. L. and KLIEWER, S. A., 2000a, St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proceedings of the National Academy of Sciences, USA, 97, 7500–7502.
   Google Scholar
• MOORE, L. B., MAGLICH, J. M., MCKEE, D. D., WISELY, B., WILLSON, T. M., KLIEWER, S. A., LAMBERT, M. H. and MOORE, J. T., 2002, Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors. Molecular Endocrinology, 16, 977–986.
   PubMed Web of Science ®Google Scholar
• MOORE, L. B., PARKS, D. J., JONES, S. A., BLEDSOE, R. K., CONSLER, T. G., STIMMEL, J. B., GOODWIN, B., LIDDLE, C., BLANCHARD, S. G., WILLSON, T. M., COLLINS, J. L. and KLIEWER, S. A., 2000b, Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. Journal of Biological Chemistry, 275, 15122–15127.
   Google Scholar
• MORGAN, E. T., 1997, Regulation of cytochromes P450 during inflammation and infection. Drug Metabolism Reviews, 29, 1129–1188.
   PubMed Web of Science ®Google Scholar
• MULLER, M., 2000, Transcriptional control of hepatocanalicular transporter gene expression. Seminars in Liver Disease, 20, 323–337.
   PubMed Web of Science ®Google Scholar
• MUNTANE-RELAT, J., OURLIN, J. C., DOMERGUE, J. and MAUREL, P., 1995, Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture. Hepatology, 22, 1143–1153.
   Google Scholar
• NAGY, S. R., Liu, G., LAM, K. S. and DENISON, M. S., 2002, Identification of novel Ah receptor agonists using a high-throughput green fluorescent protein-based recombinant cell bioassay. Biochemistry, 41, 861–868.
   PubMed Web of Science ®Google Scholar
• NEBERT, D. W., 1989, The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects. Critical Reviews in Toxicology, 20, 153–174.
   PubMed Web of Science ®Google Scholar
• NEBERT, D. W. and JONES, J. E., 1989, Regulation of the mammalian cytochrome P1-450 (CYP1A1) gene. International Journal of Biochemistry, 21, 243–252.
   PubMedGoogle Scholar
• NISHIKAWA, J., SAITO, K., SASAKI, M., TOMIGAHARA, Y. and NISHIHARA, T., 2000, Molecular cloning and functional characterization of a novel nuclear receptor similar to an embryonic benzoate receptor BXR. Biochemical and Biophysical Research Communications, 277, 209–215.
   PubMed Web of Science ®Google Scholar
• NISHIOKA, K. and REINBERG, D., 2001, Transcription. Switching partners in a regulatory tango. Science, 294, 2497–2498.
   PubMed Web of Science ®Google Scholar
• OGINO, M., NAGATA, K., MIYATA, M. and YAMAZOE, Y., 1999, Hepatocyte nuclear factor 4-mediated activation of rat CYP3A1 gene and its modes of modulation by apolipoprotein AT regulatory protein I and v-ErbA-related protein 3. Archives in Biochemistry and Biophysics, 362, 32–37.
   PubMed Web of Science ®Google Scholar
• OHTAKE, F., TAKEYAMA, K., MATSUMOTO, T., KITAGAWA, H., YAMAMOTO, Y., NOHARA, K., TOHYAMA, C., KRUST, A., MIMURA, J., CHAMBON, P., YANAGISAWA, J., FUJII-KURIYAMA, Y. and KATO, S., 2003, Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature, 423, 545–550.
   Google Scholar
• OKEY, A. B., RIDDIcK, D. S. and HARPER, P. A., 1994, Molecular biology of the aromatic hydrocarbon (dioxin) receptor. Trends in Pharmacology Science, 15, 226–232.
   PubMed Web of Science ®Google Scholar
• OREN, A., HERSCHKOVITZ, A., BEN-DROR, I., HOLDENGREBER, V., BEN-SHAUL, Y., SEGER, R. and VARDIMON, L., 1999, The cytoskeletal network controls c-Jun expression and glucocorticoid receptor transcriptional activity in an antagonistic and cell-type-specific manner. Molecular Cell Biology, 19, 1742–1750.
   Google Scholar
• OURLIN, J. C., LASSERRE, F., PINEAU, T., FABRE, J. M., SA-CUNHA, A., MAUREL, P., VILAREM, M. J. and PASCUSSI, J. M., 2003, The small heterodimer partner interacts with the pregnane X receptor and represses its transcriptional activity. Molecular Endocrinology.
   Google Scholar
• PAHL, H. L. and BAEUERLE, P. A., 1996, Control of gene expression by proteolysis. Current Opinions in Cell Biology, 8, 340–347.
   PubMed Web of Science ®Google Scholar
• PAOLINI, M., POZZETTI, L., PIAZZA, F., GUERRA, M. C., SPERONI, E., CANTELLI-FORTI, G. and RODA, A., 2000, Mechanism for the prevention of cholestasis involving cytochrome P4503A overexpression. Journal of Investigation Medicine, 48, 49–59.
   Google Scholar
• PARK, Y., LI, H. and KEMPER, B., 1996, Phenobarbital induction mediated by a distal CYP2B2 sequence in rat liver transiently transfected in situ. Journal of Biological Chemistry, 271, 23725–23728.
   PubMed Web of Science ®Google Scholar
• PARKINSON, A., 1995, Biotransformation of xenobiotics. In C. D. Klaassen (ed.), Casarett and Doull's Toxicology. The Basic Science of Poisons (New York: McGraw-Hill), pp. 113–188.
   Google Scholar
• PARKS, D. J., BLANCHARD, S. G., BLEDSOE, R. K., CHANDRA, G., CONSLER, T. G., KLIEWER, S. A., STIMMEL, J. B., WILLSON, T. M., ZAVACKI, A. M., MOORE, D. D. and LEHMANN, J. M., 1999, Bile acids: natural ligands for an orphan nuclear receptor. Science, 284, 1365–1368.
   PubMed Web of Science ®Google Scholar
• PASCUSSI, J., BUSSON-LE CONIAT, M., MAUREL, P. and VILAREM, M., 2003a, Transcriptional analysis of the orphan nuclear receptor constitutive androstane receptor (NR1I3) gene promoter: identification of a distal glucocorticoid response element. Molecular Endocrinology, 17, 42–55.
   Google Scholar
• PASCUSSI, J., GERBAL-CHALOIN, S., DAUJAT, M., DROCOURT, L., L., P.-G., M. J., V., P., M., S., K., F., T., M., B., F., G. and G., F., 2003b, CYP gene induction by xenobiotics and drugs. In J. S. 0. R. Lee and M. Fisher (eds), Drug Metabolizing Enzymes. Cytochrome P450 and Other Enzymes in Drug Discovery and Development (Lausanne: FontisMedia SA and New York: Marcel Dekker). pp. 337–374.
   Google Scholar
• PASCUSSI, J. M., DROCOURT, L., FABRE, J. M., MAUREL, P. and VILAREM, M. J., 2000a, Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators. Molecular Pharmacology, 58, 361–372.
   PubMed Web of Science ®Google Scholar
• PASCUSSI, J. M., DROCOURT, L., GERBAL-CHALOIN, S., FABRE, J. M., MAUREL, P. and VILAREM, M. J., 2001, Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. Sequential role of glucocorticoid receptor and pregnane X receptor. European Journal of Biochemistry, 268, 6346–6358.
   Google Scholar
• PASCUSSI, J. M., GERBAL-CHALOIN, S., DROCOURT, L., MAUREL, P. and VILAREM, M. J., 2003c, The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors. Biochimica et Biophysica Acta, 1619, 243–253.
   Google Scholar
• PASCUSSI, J. M., GERBAL-CHALOIN, S., FABRE, J. M., MAUREL, P. and VILAREM, M. J., 2000b, Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: consequences on cytochrome P450 gene regulation. Molecular Pharmacology, 58, 1441–1450.
   Google Scholar
• PASCUSSI, J. M., GERBAL-CHALOIN, S., PICHARD-GARCIA, L., DAUJAT, M., FABRE, J. M., MAUREL, P. and VILAREM, M. J., 2000c, Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes. Biochemical and Biophysical Research Communications, 274, 707–713.
   Google Scholar
• PASCUSSI, J. M., JOUNAIDI, Y., DROCOURT, L., DOMERGUE, J., BALABAUD, C., MAUREL, P. and VILAREM, M. J., 1999, Evidence for the presence of a functional pregnane X receptor response element in the CYP3A7 promoter gene. Biochemical and Biophysical Research Communications, 260, 377–381.
   PubMed Web of Science ®Google Scholar
• POLLENZ, R. S., 2002, The mechanism of AH receptor protein down-regulation (degradation) and its impact on AH receptor-mediated gene regulation. Chemistry and Biology Interactions, 141, 41–61.
   PubMed Web of Science ®Google Scholar
• POLLENZ, R. S., DAVARINOS, N. A. and SHEARER, T. P., 1999, Analysis of aryl hydrocarbon receptor-mediated signaling during physiological hypoxia reveals lack of competition for the aryl hydrocarbon nuclear translocator transcription factor. Molecular Pharmacology, 56, 1127–1137.
   PubMed Web of Science ®Google Scholar
• PORTER, W., WANG, F., DUAN, R., QIN, C., CASTRO-RIVERA, E., KIM, K. and SAFE, S., 2001, Transcriptional activation of heat shock protein 27 gene expression by 17beta-estradiol and modulation by antiestrogens and aryl hydrocarbon receptor agonists. Journal of Molecular Endocrinology, 26, 31–42.
   Google Scholar
• Ricci, M. S., TOSCANO, D. G., MATTINGLY, C. J. and TOSCANO, W. A., JR, 1999, Estrogen receptor reduces CYP1A1 induction in cultured human endometrial cells. Journal of Biological Chemistry, 274, 3430–3438.
   PubMed Web of Science ®Google Scholar
• ROSENFELD, J. M., VARGAS, R., JR, XIE, W. and EVANS, R. M., 2003, Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor pregnane X receptor. Molecular Endocrinology, 17, 1268–1282.
   Google Scholar
• ROUTLEDGE, E. J., WHITE, R., PARKER, M. G. and SUMPTER, J. P., 2000, Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) alpha and ERbeta. Journal of Biological Chemistry, 275, 35986–35993.
   PubMed Web of Science ®Google Scholar
• SAFE, S. and WORMKE, M., 2003, Inhibitory aryl hydrocarbon receptor—estrogen receptor alpha cross-talk and mechanisms of action. Chemical Research in Toxicology, 16, 807–816.
   PubMed Web of Science ®Google Scholar
• SAINT, S. P., SONODA, J., XU, L., TOMA, D., UPPAL, H., Mu, Y., REN, S., MOORE, D. D., EVANS, R. M. and XIE, W., 2004, A novel constitutive androstane receptor-mediated and CYP3A-independent pathway of bile acid detoxification. Molecular Pharmacology, 65, 292–300.
   PubMed Web of Science ®Google Scholar
• SCHEIDEREIT, C., 1998, Signal transduction. Docking IkappaB kinases. Nature, 395, 225–226.
   PubMed Web of Science ®Google Scholar
• SCHUETZ, E. G., STROM, S., YASUDA, K., LECUREUR, V., ASSEM, M., BRIMER, C., LAMBA, J., KIM, R. B., RAMACHANDRAN, V., KOMOROSKI, B. J., VENKATARAMANAN, R., CAI, H., SINAL, C. J., GONZALEZ, F. J. and SCHUETZ, J. D., 2001, Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. Journal of Biological Chemistry, 276, 39411–39418.
   PubMed Web of Science ®Google Scholar
• SEMENZA, G. L., 2001, Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends in Molecular Medicine, 7, 345–350.
   PubMed Web of Science ®Google Scholar
• SEOL, W., CHOI, H. S. and MOORE, D. D., 1996, An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science, 272, 1336–1339.
   PubMed Web of Science ®Google Scholar
• SEOL, W., CHUNG, M. and MOORE, D. D., 1997, Novel receptor interaction and repression domains in the orphan receptor SHP. Molecular Cell Biology, 17, 7126–7131.
   PubMed Web of Science ®Google Scholar
• SEWER, M. B. and MORGAN, E. T., 1997, Nitric oxide-independent suppression of P450 2C11 expression by interleukin-lbeta and endotoxin in primary rat hepatocytes. Biochemical Pharmacology, 54, 729–737.
   PubMed Web of Science ®Google Scholar
• SHENOY, S. D., SPENCER, T. A., MERCER-HAINES, N. A., ALIPOUR, M., GARGANO, M. D., RUNGE-MORRIS, M. and KOCAREK, T. A., 2004, CYP3A induction by liver x receptor ligands in primary cultured rat and mouse hepatocytes is mediated by the pregnane X receptor. Drug Metabolism and Disposition, 32, 66–71.
   Google Scholar
• SHEPPARD, K. A., PHELPS, K. M., WILLIAMS, A. J., THANOS, D., GLASS, C. K., ROSENFELD, M. G., GERRITSEN, M. E. and COLLINS, T., 1998, Nuclear integration of glucocorticoid receptor and nuclear factor-kappaB signaling by CREB-binding protein and steroid receptor coactivator-1. Journal of Biological Chemistry, 273, 29291–29294.
   PubMed Web of Science ®Google Scholar
• SHIMADA, T., INouE, K., SUZUKI, Y., KAWAI, T., AZUMA, E., NAKAJIMA, T., SHINDO, M., KUROSE, K., SUGIE, A., YAMAGISHI, Y., FUJII-KURIYAMA, Y. and HASHIMOTO, M., 2002, Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice. Carcinogenesis, 23, 1199–1207.
   Google Scholar
• SHIMADA, T., YAMAZAKI, H., MIMURA, M., INUI, Y. and GUENGERICH, F. P., 1994, Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. Journal of Pharmacology and Experimental Therapeutics, 270, 414–423.
   PubMed Web of Science ®Google Scholar
• SHIRAKI, T., SAKAI, N., KANAYA, E. and JINGAmi, H., 2003, Activation of orphan nuclear constitutive androstane receptor requires subnuclear targeting by peroxisome proliferator-activated receptor gamma coactivator-1 alpha. A possible link between xenobiotic response and nutritional state. Journal of Biological Chemistry, 278, 11344–11350.
   PubMed Web of Science ®Google Scholar
• SHIVERICK, K. T. and MUTHER, T. F., 1982, Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on serum concentrations and the uterotrophic action of exogenous estrone in rats. Toxicology and Applied Pharmacology, 65, 170–176.
   PubMed Web of Science ®Google Scholar
• SLADEK, F. M., ZHONG, W. M., LAI, E. and DARNELL, J. E., JR, 1990, Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes and Development, 4, 2353–2365.
   PubMed Web of Science ®Google Scholar
• SOGAWA, K. and FUJII-KURIYAMA, Y., 1997, Ah receptor, a novel ligand-activated transcription factor. Journal of Biochemistry (Tokyo), 122, 1075–1079.
   Google Scholar
• SONG, Z. and POLLENZ, R. S., 2002, Ligand-dependent and independent modulation of aryl hydrocarbon receptor localization, degradation, and gene regulation. Molecular Pharmacology, 62, 806–816.
   PubMed Web of Science ®Google Scholar
• SOUTOGLOU, E. and TALIANIDIS, I., 2002, Coordination of PIC assembly and chromatin remodeling during differentiation-induced gene activation. Science, 295, 1901–1904.
   PubMed Web of Science ®Google Scholar
• SPECTOR, D. L., 2003, The dynamics of chromosome organization and gene regulation. Annual Review in Biochemistry, 72, 573–608.
   PubMed Web of Science ®Google Scholar
• ST JOHNSTON, D., 1995, The intracellular localization of messenger RNAs. Cell, 81, 161-170. STALLCUP, M. R., 2001, Role of protein methylation in chromatin remodeling and transcriptional regulation. Oncogene, 20, 3014–3020.
   Google Scholar
• STAUDINGER, J. L., GOODWIN, B., JONES, S. A., HAWKINS-BROWN, D., MACKENZIE, K. I., LATouR, A., Liu, Y., KLAASSEN, C. D., BROWN, K. K., REINHARD, J., WILLSON, T. M., KoLLER, B. H. and KLIEWER, S. A., 2001b, The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proceedings of the National Academy of Sciences, USA, 98, 3369–3374.
   Google Scholar
• STAUDINGER, J., Liu, Y., MADAN, A., HABEEBU, S. and KLAASSEN, C. D., 2001a, Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor. Drug Metabolism and Disposition, 29, 1467–1472.
   PubMed Web of Science ®Google Scholar
• STIEGER, B. and MEIER, P. J., 1998, Bile acid and xenobiotic transporters in liver. Current Opinions in Cell Biology, 10, 462–467.
   PubMed Web of Science ®Google Scholar
• SUEYOSHI, T., KAWAMOTO, T., ZELKO, I., HONKAKOSKI, P. and NEGISHI, M., 1999, The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. Journal of Biological Chemistry, 274, 6043–6046.
   PubMed Web of Science ®Google Scholar
• SUGATANI, J., KOJIMA, H., UEDA, A., KAKIZAKI, S., YOSHINARI, K., GONG, Q. H., OWENS, I. S., NEGISHI, M. and SUEYOSHI, T., 2001, The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology, 33, 1232–1238.
   PubMed Web of Science ®Google Scholar
• SYNOLD, T. W., DUSSAULT, I. and FORMAN, B. M., 2001, The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nature Medicine, 7, 584–590.
   PubMed Web of Science ®Google Scholar
• TABB, M. M., KHOLODOVYCH, V., GRUN, F., ZHOU, C., WELSH, W. J. and BLUMBERG, B., 2004, Highly chlorinated PCBs inhibit the human xenobiotic response mediated by the steroid and xenobiotic receptor (SXR). Environmental Health Perspectives, 112, 163–169.
   PubMed Web of Science ®Google Scholar
• THUMMEL, K. E., BRIMER, C., YASUDA, K., THOTTASSERY, J., SENN, T., LIN, Y., IsHizuRA, H., KHARASCH, E., SCHUETZ, J. and SCHUETZ, E., 2001, Transcriptional control of intestinal cytochrome P-4503A by lalpha,25-dihydroxy vitamin D3. Molecular Pharmacology, 60, 1399–1406.
   PubMed Web of Science ®Google Scholar
• TIRONA, R. G., LEE, W., LEAKE, B. F., LAN, L. B., CLINE, C. B., LAMBA, V., PARVIZ, F., DUNCAN, S. A., INouE, Y., GONZALEZ, F. J., SCHUETZ, E. G. and KIM, R. B., 2003, The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4. Nature Medicine, 9, 220–224.
   PubMed Web of Science ®Google Scholar
• TRAUNER, M., FICKERT, P. and STAUBER, R. E., 1999, Inflammation-induced cholestasis. Journal of Gastroenterology and Hepatology, 14, 946–959.
   PubMed Web of Science ®Google Scholar
• TROTTIER, E., BELZIL, A., STOLTZ, C. and ANDERSON, A., 1995, Localization of a phenobarbital-responsive element (PBRE) in the 5'-flanking region of the rat CYP2B2 gene. Gene, 158, 263–268.
   PubMed Web of Science ®Google Scholar
• TZAMELI, I., Pissios, P., SCHUETZ, E. G. and MOORE, D. D., 2000, The xenobiotic compound 1,4-bis[2-(3, 5-dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CAR. Molecular Cell Biology, 20, 2951–2958.
   PubMed Web of Science ®Google Scholar
• WANG, H., FAUCETTE, S., SUEYOSHI, T., MOORE, R., FERGUSON, S., NEGISHI, M. and LECLUYSE, E. L., 2003, A novel distal enhancer module regulated by pregnane X receptor/constitutive androstane receptor is essential for the maximal induction of CYP2B6 gene expression. Journal of Biological Chemistry, 278, 14146–14152.
   PubMed Web of Science ®Google Scholar
• WATKINS, R. E., MAGLICH, J. M., MOORE, L. B., WISELY, G. B., NOBLE, S. M., DAVIS-SEARLES, P. R., LAMBERT, M. H., KLIEWER, S. A. and REDINBO, M. R., 2003,2.1 A crystal structure of human PXR in complex with the St. John's wort compound hyperforin. Biochemistry, 42, 1430–1438.
   Google Scholar
• WATKINS, R. E., WISELY, G. B., MOORE, L. B., COLLINS, J. L., LAMBERT, M. H., WILLIAMS, S. P., WILLSON, T. M., KLIEWER, S. A. and REDINBO, M. R., 2001, The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science, 292, 2329–2333.
   PubMed Web of Science ®Google Scholar
• WAXMAN, D. J., 1999, P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR. Archives in Biochemistry and Biophysics, 369, 11–23.
   PubMed Web of Science ®Google Scholar
• WEI, P., ZHANG, J., EGAN-HAFLEY, M., LIANG, S. and MOORE, D. D., 2000a, The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature, 407, 920–923.
   PubMed Web of Science ®Google Scholar
• WEI, Y. D., BERGANDER, L., RANNUG, U. and RANNUG, A., 2000b, Regulation of CYP1A1 transcription via the metabolism of the tryptophan-derived 6-formylindolo[3,2-b]carbazole. Archives in Biochemistry and Biophysics, 383, 99–107.
   PubMed Web of Science ®Google Scholar
• WHITLOCK, J. P., JR, 1999, Induction of cytochrome P4501A1 . Annual Reviews in Pharmacology and Toxicology, 39, 103–125.
   PubMed Web of Science ®Google Scholar
• WIJAYARATNE, A. L. and MCDONNELL, D. P., 2001, The human estrogen receptor-alpha is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators. Journal of Biological Chemistry, 276, 35684–35692.
   PubMed Web of Science ®Google Scholar
• WOLFFE, A. P., 2001, Chromatin remodeling: why it is important in cancer. Oncogene, 20, 2988–2990.
   PubMed Web of Science ®Google Scholar
• WORMKE, M., STONER, M., SAVILLE, B., WALKER, K., ABDELRAHIM, M., BURGHARDT, R. and SAFE, S., 2003, The aryl hydrocarbon receptor mediates degradation of estrogen receptor alpha through activation of proteasomes. Molecular Cell Biology, 23, 1843–1855.
   PubMed Web of Science ®Google Scholar
• XIE, W., RADOMINSKA-PANDYA, A., SHI, Y., SIMON, C. M., NELSON, M. C., ONG, E. S., WAXMAN, D. J. and EVANS, R. M., 2001, An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proceedings of the National Academy of Sciences, USA, 98, 3375–3380.
   Google Scholar
• XIE, W., YEUH, M. F., RADOMINSKA-PANDYA, A., SAINI, S. P., NEGISHI, Y., BOTTROFF, B. S., CABRERA, G. Y., TUKEY, R. H. and EVANS, R. M., 2003, Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proceedings of the National Academy of Sciences, USA, 100, 4150–4155.
   Google Scholar
• YOSHINARI, K., KOBAYASHI, K., MOORE, R., KAWAMOTO, T. and NEGISHI, M., 2003, Identification of the nuclear receptor CAR:HSP90 complex in mouse liver and recruitment of protein phosphatase 2A in response to phenobarbital. FEBS Letters, 548, 17–20.
   PubMed Web of Science ®Google Scholar
• ZELKO, I. and NEGISHI, M., 2000, Phenobarbital-elicited activation of nuclear receptor CAR in induction of cytochrome P450 genes. Biochemical and Biophysical Research Communications, 277, 1–6.
   PubMed Web of Science ®Google Scholar
• ZELKO, I., SUEYOSHI, T., KAWAMOTO, T., MOORE, R. and NEGISHI, M., 2001, The peptide near the C terminus regulates receptor CAR nuclear translocation induced by xenochemicals in mouse liver. Molecular Cell Biology, 21, 2838–2846.
   PubMed Web of Science ®Google Scholar
• ZHANG, J., HUANG, W., CHUA, S. S., WEI, P. and MOORE, D. D., 2002, Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR. Science, 298, 422–424.
   PubMed Web of Science ®Google Scholar
• ZHANG, J., KUEHL, P., GREEN, E. D., TOUCHMAN, J. W., WATKINS, P. B., DALY, A., HALL, S. D., MAUREL, P., RELLING, M., BRIMER, C., YASUDA, K., WRIGHTON, S. A., HANCOCK, M., KIM, R. B., STROM, S., THUMMEL, K., RUSSELL, C. G., HUDSON, J. R., JR, SCHUETZ, E. G. and BOGUSKI, M. S., 2001, The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants. Pharmacogenetics, 11, 555–572.
   Google Scholar
• ZHou, Z., CORDEN, J. L. and BROWN, T. R., 1997, Identification and characterization of a novel androgen response element composed of a direct repeat. Journal of Biological Chemistry, 272, 8227–8235.
   PubMed Web of Science ®Google Scholar